Multinational Drugmakers Taking Advantage Of Opportunities In MENA Pharmaceuticals

BMI View: Unhealthy lifestyle choices across the Middle East and North Africa (MENA) have made the incidence of chronic diseases very high considering the low average age. Demand for treatment for circulatory disease, diabetes mellitus, oral conditions and cancer will grow at rapid rates in the short to medium term, further boosted in monetary terms by the effects of drug price inflation. This is a huge opportunity for drugmakers, not only in the more obvious clinical areas that make the most headlines, such as diabetes and heart disease, but across the spectrum of chronic

To read the full article, please choose one of the following options: